<DOC>
	<DOCNO>NCT02571998</DOCNO>
	<brief_summary>The primary objective study evaluate safety efficacy Omiganan ( CLS001 ) topical gel compare vehicle topical gel apply daily 12 week female subject moderate severe inflammatory acne vulgaris .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy Omiganan ( CLS001 ) Topical Gel Versus Vehicle Female Subjects With Moderate Severe Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Nonpregnant female subject ≥ 12 year age facial acne vulgaris Subjects Investigator 's Global Assessment ( IGA ) Inflammatory Lesions Acne Vulgaris Moderate ( 3 ) Severe ( 4 ) Baseline . Subjects ≥ 30 facial inflammatory lesion Subjects &lt; 10 &gt; 75 facial noninflammatory lesion Subjects &gt; 3 facial nodular cystic lesion Baseline Standard exclusion criterion</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>